FOR THE BENEFIT OF THOSE FOLLOWING USCOM, BUT NOT EXISTING...

FOR THE BENEFIT OF THOSE FOLLOWING USCOM, BUT NOT EXISTING SHAREHOLDERS - posted here-under is the full text of the shareholders letter and invitation to Thursday next video presentation.

As Rob Phillips Chairman and CEO and acknowledged world leader in his field says at the bottom of his News release:
Summary: "For Uscom the rapidly accelerating COVID-19 recovery cycle in China and expanding pandemic internationally is providing a platform for our widespread adoption.
This adoption is transforming the company and this presentation will be useful for investors wishing to increase exposure to the global Health Care sector."

Uscom News for Investors Virtual Investor Presentation - Thurs 26th March at 2:10pm Dear Investors, It gives me pleasure to invite you to join us in a Virtual Investor Presentation being hosted by NWR Communications onThurs 26th March at 2:10pm. This will give me an opportunity to update investors on important Uscom progress over the last 2.5 months in a 20-25 minute presentation followed by a few questions. Importantly we are about to close Q3 and prepare our 4C for the market. The 4C is an important measure of the cash receipts and cash flow sustainability of an entity and so is a critical corporate performance measure for investors. While the 4C will be released following formal accounting review after closure of the period (31st of March), this presentation will allow investors to review up to date information of operations in Uscom China, Europe, and the US since January, and view strategies and expectations going forward. --> Virtual Investor Presentation Thurs 26th March at 2:10pm To register for the FREE event REGISTER TO ATTEND Free registration online: https://organizer.runtheworld.today/invitation/670 Investors can submit questions prior to the event- send(by 5 pm AEDT Wednesday 25th March)to[email protected]. --> Uscom China is a wholly-owned Uscom subsidiary, with permits and approvals to sell all type II medical devices in China, import devices, employ staff, operate a capital account, and, importantly, has just received a 5-year NMPA re-approval to sell the USCOM 1A in China. As the rest of the world engages with the COVID-19 pandemic, Uscom China is ideally poised to leverage the recommendations of the China National Health and Medical Commission (adults and children) recommendation that the USCOM 1A is a preferred technology for the treatment of severe COVID-19 cases and sepsis. Additionally, the US based Society of Critical Care Medicine recommended the 1A as a standard of care for paediatric sepsis, including COVID-19. As a result, Uscom is currently being evaluated in a number of Chinese and international tenders to supply 1A devices to hospitals in need, and Uscom is focused on drawing the attention of medical device purchasers to the Government and Academic endorsement of our USCOM 1A. Uscom is proud to be collaborating with the Chinese Government and clinicians, and contributing to the successful treatment of many COVID-19 patients, and ultimately the successful control of the disease in China. We look forward to the USCOM 1A making life saving contributions to the treatment of patients in Europe and the US as the pandemic continues to spread. Summary: For Uscom the rapidly accelerating COVID-19 recovery cycle in China and expanding pandemic internationally is providing a platform for our widespread adoption. This adoption is transforming the company and this presentation will be useful for investors wishing to increase exposure to the global Health Care sector. We look forward to you joining us for this virtual symposium on Thursday. For those of you who cannot make it we will, in line with our corporate governance requirements, lodge the .ppt with the ASX as we begin the presentation. Free registration online: https://organizer.runtheworld.today/invitation/670 Investors can submit questions prior to the event (by 5 pm AEDT Wednesday 25th March) to [email protected]. Kinds regards, Prof Rob Phillips